Suppr超能文献

相似文献

1
RNA-mediated neurodegeneration in repeat expansion disorders.
Ann Neurol. 2010 Mar;67(3):291-300. doi: 10.1002/ana.21948.
2
CAG repeat RNA as an auxiliary toxic agent in polyglutamine disorders.
RNA Biol. 2011 Jul-Aug;8(4):565-71. doi: 10.4161/rna.8.4.15397. Epub 2011 Jul 1.
3
Repeat RNA expansion disorders of the nervous system: post-transcriptional mechanisms and therapeutic strategies.
Crit Rev Biochem Mol Biol. 2021 Feb;56(1):31-53. doi: 10.1080/10409238.2020.1841726. Epub 2020 Nov 10.
4
Trinucleotide repeat disorders.
Annu Rev Neurosci. 2007;30:575-621. doi: 10.1146/annurev.neuro.29.051605.113042.
5
Gain of RNA function in pathological cases: Focus on myotonic dystrophy.
Biochimie. 2011 Nov;93(11):2006-12. doi: 10.1016/j.biochi.2011.06.028. Epub 2011 Jul 13.
6
RNA-dominant diseases.
Hum Mol Genet. 2006 Oct 15;15 Spec No 2:R162-9. doi: 10.1093/hmg/ddl181.
7
RNA-binding proteins in microsatellite expansion disorders: mediators of RNA toxicity.
Brain Res. 2012 Jun 26;1462:100-11. doi: 10.1016/j.brainres.2012.02.030. Epub 2012 Feb 22.
8
Repeat-associated non-AUG translation from antisense CCG repeats in fragile X tremor/ataxia syndrome.
Ann Neurol. 2016 Dec;80(6):871-881. doi: 10.1002/ana.24800. Epub 2016 Nov 26.
9
Fragile X-associated tremor/ataxia syndrome--an older face of the fragile X gene.
Nat Clin Pract Neurol. 2007 Feb;3(2):107-12. doi: 10.1038/ncpneuro0373.
10
RNA-mediated neuromuscular disorders.
Annu Rev Neurosci. 2006;29:259-77. doi: 10.1146/annurev.neuro.29.051605.113014.

引用本文的文献

1
Decoding the Alphabet Soup: A Practical Guide to Genetic Testing in Hyperkinetic Movement Disorders.
Tremor Other Hyperkinet Mov (N Y). 2025 Jun 26;15:28. doi: 10.5334/tohm.971. eCollection 2025.
2
Use of HSA female mice as a model for the study of myotonic dystrophy type I.
Lab Anim (NY). 2025 Apr;54(4):92-102. doi: 10.1038/s41684-025-01506-7. Epub 2025 Feb 27.
3
Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy.
Cochrane Database Syst Rev. 2024 Nov 18;11(11):CD003218. doi: 10.1002/14651858.CD003218.pub3.
4
Mapping of repeat-associated non-AUG (RAN) translation knowledge: A bibliometric analysis.
Heliyon. 2024 Apr 2;10(8):e29141. doi: 10.1016/j.heliyon.2024.e29141. eCollection 2024 Apr 30.
5
Advances in the discovery and analyses of human tandem repeats.
Emerg Top Life Sci. 2023 Dec 14;7(3):361-381. doi: 10.1042/ETLS20230074.
8
Small molecules targeting different cellular pathologies for the treatment of amyotrophic lateral sclerosis.
Med Res Rev. 2023 Nov;43(6):2260-2302. doi: 10.1002/med.21974. Epub 2023 May 26.
10
G-Quadruplexes in Repeat Expansion Disorders.
Int J Mol Sci. 2023 Jan 25;24(3):2375. doi: 10.3390/ijms24032375.

本文引用的文献

1
Pentamidine reverses the splicing defects associated with myotonic dystrophy.
Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18551-6. doi: 10.1073/pnas.0903234106. Epub 2009 Oct 12.
2
A simple ligand that selectively targets CUG trinucleotide repeats and inhibits MBNL protein binding.
Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16068-73. doi: 10.1073/pnas.0901824106. Epub 2009 Sep 8.
3
RNA gain-of-function in spinocerebellar ataxia type 8.
PLoS Genet. 2009 Aug;5(8):e1000600. doi: 10.1371/journal.pgen.1000600. Epub 2009 Aug 14.
4
Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy.
Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13915-20. doi: 10.1073/pnas.0905780106. Epub 2009 Aug 10.
5
Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA.
Science. 2009 Jul 17;325(5938):336-9. doi: 10.1126/science.1173110.
8
Rethinking ALS: the FUS about TDP-43.
Cell. 2009 Mar 20;136(6):1001-4. doi: 10.1016/j.cell.2009.03.006.
9
RNA and disease.
Cell. 2009 Feb 20;136(4):777-93. doi: 10.1016/j.cell.2009.02.011.
10
Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophy.
Hum Mol Genet. 2009 Apr 15;18(8):1471-81. doi: 10.1093/hmg/ddp058. Epub 2009 Feb 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验